Colleen Labelle, MSN
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
General Internal Medicine

MSN, Grand Canyon College
RN, St Elizabeths Hosp

09/12/2019 - 05/31/2024 (PI)
Kaiser Foundation Research Institute National Institute o

Treating Chronic Pain in Buprenorphine Patients in Primary
02/15/2019 - 01/31/2024 (PI)
Trustees of Boston University, BUMC National Institutes

BMC OBAT Training and Technical Assistance (OBAT TTA) - SUSTAIN TTA PLUS
03/01/2019 - 12/31/2022 (PI)
GE Healthcare

Pre-Notification OBOT Training and Technical Assistance
09/30/2021 - 09/29/2022 (PI)
Massachusetts Dept. of Public Health / DPH

04/01/2021 - 09/29/2022 (PI)
Massachusetts Dept. of Public Health / DPH Substance Abuse and

State Opioid Response Technical Assistance (SOR-TA)
09/30/2020 - 09/29/2022 (PI)
American Academy of Addiction Psychiatry Substance Abuse and

Office Based Opioid Treatment
07/01/2017 - 06/30/2022 (PI)

OBOT Training and Technical Assistance
07/15/2007 - 06/30/2022 (PI)
Massachusetts Dept. of Public Health / DPH Substance Abuse and

Primary Care Opoid Use Disorders Treatment(PROUD) Trial YR02
06/01/2020 - 02/28/2022 (PI)
Kaiser Permanente National Institute o

Medication for Opioid Use Disorder in Long-term Care Technic
04/26/2021 - 12/31/2021 (PI)
ABT Associates Inc. Massachusetts Dept.

Showing 10 of 25 results. Show All Results


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Heerema MR, Ventura AS, Blakemore SC, Montoya ID, Gobel DE, Kiang MV, LaBelle CT, Bazzi AR. Evaluation of the New England Office Based Addiction Treatment ECHO: A Tool for Strengthening the Addiction Workforce. Subst Abus. 2023 Jun 07; 8897077231179601.View Related Profiles. PMID: 37287240
  2. Komaromy M, Tomanovich M, Taylor JL, Ruiz-Mercado G, Kimmel SD, Bagley SM, Saia KM, Costello E, Park TW, LaBelle C, Weinstein Z, Walley AY. Adaptation of a System of Treatment for Substance Use Disorders During the COVID-19 Pandemic. J Addict Med. 2021 Nov-Dec 01; 15(6):448-451.View Related Profiles. PMID: 33298750; PMCID: PMC8562917; DOI: 10.1097/ADM.0000000000000791;
  3. Wason K, Potter A, Alves J, Loukas VL, Lastimoso C, Sodder S, Caputo A, LaBelle CT. Addiction Nursing Competencies: A Comprehensive Toolkit for the Addictions Nurse. J Nurs Adm. 2021 Sep 01; 51(9):424-429.View Related Profiles. PMID: 34411061
  4. Tsui JI, Leroux BG, Radick AC, Schramm ZA, Blalock K, Labelle C, Heerema M, Klein JW, Merrill JO, Saxon AJ, Samet JH, Kim TW. Video directly observed therapy for patients receiving office-based buprenorphine - A pilot randomized controlled trial. Drug Alcohol Depend. 2021 10 01; 227:108917.View Related Profiles. PMID: 34399136; PMCID: PMC8464515; DOI: 10.1016/j.drugalcdep.2021.108917;
  5. Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.View Related Profiles. PMID: 33517894; PMCID: PMC7849121; DOI: 10.1186/s13722-021-00218-w;
  6. Bagley SM, Cheng DM, Winter M, Alford DP, LaBelle C, Walley AY, Samet JH. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests. Drug Alcohol Depend. 2018 11 01; 192:245-249.View Related Profiles. PMID: 30290291; PMCID: PMC6291245; DOI: 10.1016/j.drugalcdep.2018.08.010;
  7. Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 08 01; 189:166-171.View Related Profiles. PMID: 29958128; PMCID: PMC6139651; DOI: 10.1016/j.drugalcdep.2018.05.010;
  8. Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19.View Related Profiles. PMID: 28673522; PMCID: PMC5522736; DOI: 10.1016/j.jsat.2017.05.010;
  9. Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH. Long-term retention in Office Based Opioid Treatment with buprenorphine. J Subst Abuse Treat. 2017 Mar; 74:65-70.View Related Profiles. PMID: 28132702; PMCID: PMC5312773; DOI: 10.1016/j.jsat.2016.12.010;
  10. LaBelle CT, Han SC, Bergeron A, Samet JH. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. J Subst Abuse Treat. 2016 Jan; 60:6-13.View Related Profiles. PMID: 26233698; PMCID: PMC4682362; DOI: 10.1016/j.jsat.2015.06.010;
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 12 distinct years, with a maximum of 4 publications in 2021

Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map

Labelle's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department